Tobacco Smoking Is Not Associated With Accelerated Liver Disease in Human Immunodeficiency Virus-Hepatitis C Coinfection: A Longitudinal Cohort Analysis.

PubWeight™: 0.77‹?›

🔗 View Article (PMID 27047987)

Published in Open Forum Infect Dis on March 07, 2016

Authors

Cecilia T Costiniuk1, Laurence Brunet2, Kathleen C Rollet-Kurhajec1, Curtis L Cooper3, Sharon L Walmsley4, M John Gill5, Valérie Martel-Laferriere6, Marina B Klein7

Author Affiliations

1: Chronic Viral Illnesses Service , Division of Infectious Diseases and Research Institute of the McGill University Health Centre , Montreal.
2: Department of Epidemiology , Biostatistics and Occupational Health, McGill University , Montreal, Quebec.
3: Division of Infectious Diseases, The Ottawa Hospital, Ontario, Canada; Canadian HIV Trials Network, Vancouver, British Columbia.
4: Canadian HIV Trials Network, Vancouver, British Columbia; Division of Infectious Diseases, University Health Network, University of Toronto, Ontario.
5: Canadian HIV Trials Network, Vancouver, British Columbia; Southern Alberta HIV Clinic, Calgary.
6: Centre de Recherche du Centre Hospitalier de l'Université de Montréal , Quebec , Canada.
7: Chronic Viral Illnesses Service, Division of Infectious Diseases and Research Institute of the McGill University Health Centre, Montreal; Canadian HIV Trials Network, Vancouver, British Columbia.

Articles cited by this

Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology (1999) 5.75

Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group. Hepatology (1999) 5.55

Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis. Hepatology (2011) 3.38

Progression of fibrosis in chronic hepatitis C. Gastroenterology (2003) 2.77

HIV coinfection shortens the survival of patients with hepatitis C virus-related decompensated cirrhosis. Hepatology (2005) 2.42

Smoking and severity of hepatic fibrosis in nonalcoholic fatty liver disease. J Hepatol (2010) 2.42

Liver pathology in morbidly obese patients with and without diabetes. Am J Gastroenterol (1990) 2.13

Regional, disease specific patterns of smoking-attributable mortality in 2000. Tob Control (2004) 2.12

Meta-analysis of epidemiologic studies on cigarette smoking and liver cancer. Int J Epidemiol (2009) 2.11

Smoking induces insulin resistance--a potential link with the insulin resistance syndrome. J Intern Med (1993) 2.01

Nonalcoholic fatty liver disease in patients with type 2 diabetes. Clin Gastroenterol Hepatol (2004) 1.95

Progression of hepatic fibrosis in patients with hepatitis C: a prospective repeat liver biopsy study. Gut (2004) 1.93

Insulin resistance, the metabolic syndrome, and nonalcoholic fatty liver disease. J Clin Endocrinol Metab (2004) 1.68

The Coding Causes of Death in HIV (CoDe) Project: initial results and evaluation of methodology. Epidemiology (2011) 1.59

Cigarette smoking and hepatic lesions in patients with chronic hepatitis C. Hepatology (2001) 1.51

Cigarette smoking prevalence among adults with HIV compared with the general adult population in the United States: cross-sectional surveys. Ann Intern Med (2015) 1.48

Impact of smoking on histological liver lesions in chronic hepatitis C. Gut (2003) 1.40

Glucose tolerance and smoking: a population study of oral and intravenous glucose tolerance tests in middle-aged men. Diabetologia (1983) 1.34

Heavy smoking and liver. World J Gastroenterol (2006) 1.33

Chronic ethanol and nicotine interaction on rat tissue antioxidant defense system. Alcohol (2001) 1.30

Evaluating liver fibrosis progression and the impact of antiretroviral therapy in HIV and hepatitis C coinfection using a noninvasive marker. J Acquir Immune Defic Syndr (2007) 1.28

Prediction of liver fibrosis in human immunodeficiency virus/hepatitis C virus coinfected patients by simple non-invasive indexes. Gut (2005) 1.28

Validation of a simple model for predicting liver fibrosis in HIV/hepatitis C virus-coinfected patients. HIV Med (2005) 1.22

Cohort profile: the Canadian HIV-hepatitis C co-infection cohort study. Int J Epidemiol (2009) 1.17

HCV and HIV co-infection: mechanisms and management. Nat Rev Gastroenterol Hepatol (2014) 1.16

Global trends of lung cancer mortality and smoking prevalence. Transl Lung Cancer Res (2015) 1.11

Socioeconomic risk factors for bacteraemic pneumococcal pneumonia in adults. Epidemiol Infect (2008) 1.04

Chronic liver diseases for the risk of hepatocellular carcinoma: a case-control study in Japan. Etiologic association of alcohol consumption, cigarette smoking and the development of chronic liver diseases. Hepatogastroenterology (1999) 1.00

Estimating past hepatitis C infection risk from reported risk factor histories: implications for imputing age of infection and modeling fibrosis progression. BMC Infect Dis (2007) 1.00

The effect of nicotine and its interaction with carbon tetrachloride in the rat liver. Pharmacol Toxicol (1995) 0.93

Risk of cardiovascular disease associated with HCV and HBV coinfection among antiretroviral-treated HIV-infected individuals. Antivir Ther (2014) 0.92

Relationship of smoking and fibrosis in patients with chronic hepatitis C. Clin Gastroenterol Hepatol (2006) 0.91

Trends in tobacco-attributable mortality in France. Eur J Public Health (2015) 0.90

Hepatitis C virus coinfection independently increases the risk of cardiovascular disease in HIV-positive patients. J Viral Hepat (2015) 0.89

Change in fibrosis score as a predictor of mortality among HIV-infected patients with viral hepatitis. AIDS Patient Care STDS (2012) 0.89

Noninvasive diagnosis of liver fibrosis in patients with HIV infection and HCV/HBV co-infection. J Viral Hepat (2009) 0.88

Smoking is associated with steatosis and severe fibrosis in chronic hepatitis C but not B. Scand J Gastroenterol (2009) 0.86

The epidemiology of community acquired bacteremic pneumonia, due to Streptococcus pneumoniae, in the Top End of the Northern Territory, Australia--over 22 years. Vaccine (2011) 0.85

Effect of cigarette smoke on lipid peroxidation and liver function tests in rats. Acta Med Okayama (1995) 0.84

Tobacco and other factors have a negative impact on quality of life in hepatitis C patients. J Viral Hepat (2010) 0.78